Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Neuer Gesetzesentwurf!: Kommt nach der Cannabis-Neuregulierung nun eine komplette Legalisierung in USA?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
105 Leser
Artikel bewerten:
(0)

ORFLO Launches First Hands-free Mini Automated Cell Counter

ORLANDO, Fla., April 3, 2011 /PRNewswire/ -- ORFLO Technologies announced the international launch of Moxi(TM) Z, the life science industry's first hands-free mini automated cell counter at the American Association for Cancer Research Annual Meeting in Orlando.

(Photo: http://photos.prnewswire.com/prnh/20110403/SF76326 )

"The Moxi Z mini cell counter sets a new bar for the cell counting community," said Manju Sethi, Vice President of Business Development, "The instrument eliminates virtually all of the drawbacks of current cell counting methods."

Today, cell counting is often performed by using hemocytometers that involve laborious manual counting or by using large, imprecise image-based counting systems. When more accurate data is needed, scientists turn to flow cytometers that can be very costly.

Moxi Z combines two powerful methods, the Coulter Principle which is the gold standard for cell counting and a patented thin-film sensor technology developed by ORFLO. This unique instrument has the performance of high-end instruments yet is miniaturized, affordable and simple to operate without the need for costly reagents or maintenance contracts.

In just 8 seconds per measurement, the instrument provides accurate cell size and count determinations and an indicator of dead versus live cells with its Moxi Viability Index - an important criterion for scientists who are analyzing cell cultures. The Moxi Z is the first portable instrument to provide cell viability without the use of reagents or dyes. Moxi Z's disposable cassettes offer superior ease of use and cost effectiveness with two tests per cassette.

"Cell science is evolving rapidly today, and Moxi z plays a revolutionary role in optimizing the scientist's toolkit to quickly and affordably answer many of the quantitative and qualitative questions that scientists ask themselves about their cell cultures," summarizes Ted Ayliffe, ORFLO founder and CEO.

Orflo Technologies is a Seattle-based, privately-held leading edge biotechnology company with a strong intellectual property portfolio focused on developing high-precision, inexpensive portable instruments for cell analysis. Orflo is leveraging its innovative proprietary technology platform to revolutionize cell counting in both the life science and diagnostic industries. ORFLO and Moxi are trademarks of ORFLO Technologies.

For more information, contact Pia Ayliffe at: http://www.orflo.com/ Address: 18916 North Creek Parkway, Building 2, Bothell, WA 98011 Phone: +1 425 806-0002 Email: info@orflo.com

Photo: http://photos.prnewswire.com/prnh/20110403/SF76326
AP PhotoExpress Network: PRN1
PRN Photo Desk, photodesk@prnewswire.com

ORFLO Technologies

Web site: http://www.orflo.com/

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2011 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.